A pharmaceutical company is trying to block Colorado’s first-in-the-nation drug price cap in court
The lawsuit, by the drug-maker Amgen, is looking to overturn a decision by Colorado’s Prescription Drug Affordability Board to cap the price on Enbrel
Original Source
Read the full article at Coloradosun →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.